Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / COM NEW
-
Number of holders
-
18
-
Total 13F shares, excl. options
-
91,313
-
Shares change
-
+29,401
-
Total reported value, excl. options
-
$1,278,548
-
Value change
-
+$420,748
-
Number of buys
-
7
-
Number of sells
-
-5
-
Price
-
$14
Significant Holders of MiNK Therapeutics, Inc. - COM NEW (INKT) as of Q3 2025
21 filings reported holding INKT - MiNK Therapeutics, Inc. - COM NEW as of Q3 2025.
MiNK Therapeutics, Inc. - COM NEW (INKT) has 18 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 91,313 shares
.
Largest 10 shareholders include VANGUARD GROUP INC (33,351 shares), Longbow Finance SA (16,667 shares), RENAISSANCE TECHNOLOGIES LLC (14,600 shares), GEODE CAPITAL MANAGEMENT, LLC (12,806 shares), BlackRock, Inc. (6,298 shares), UBS Group AG (5,648 shares), Tower Research Capital LLC (TRC) (926 shares), BANK OF AMERICA CORP /DE/ (568 shares), Covestor Ltd (131 shares), and OSAIC HOLDINGS, INC. (124 shares).
This table shows the top 18 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.